Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma
Sathish Gopalakrishnan(Science North), Parameswaran Hari(Medical College of Wisconsin), Siddhartha Ganguly(University of Kansas Medical Center), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center), Gerhard Hildebrandt(University of Missouri Health System), Frederick L. Locke(Moffitt Cancer Center), Cindy Lee(University of Toronto), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Raphael Fraser(University at Buffalo, State University of New York), Yago Nieto(The University of Texas MD Anderson Cancer Center), Cristina Gasparetto(Dana-Farber Cancer Institute), Anita D’Souza, Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Jesús G. Berdeja(Tennessee Oncology), Amer Assal(Columbia University Irving Medical Center), Sachiko Seo(National Cancer Center Hospital East), Nina Shah(The University of Texas MD Anderson Cancer Center), Tomer M. Mark(University of Colorado Hospital), Binod Dhakal(Medical College of Wisconsin), Taiga Nishihori(Moffitt Cancer Center), Abraham S. Kanate(HonorHealth), Usama Gergis(Thomas Jefferson University Hospital), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Emma C. Scott(Oregon Health & Science University), Kenneth R. Meehan(Dartmouth–Hitchcock Medical Center), Rammurti T. Kamble(Baylor College of Medicine), Melhem Solh(Johns Hopkins Hospital), Tamila L. Kindwall‐Keller(MetroHealth Medical Center), Omar Dávila(Medical College of Wisconsin)
Cited by 28
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k